Project Grant R01CA315618
Award Date 9/1/26
Completion Date 8/30/31
Dollars Obligated $641K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $599,978 under the Cancer Cause and Prevention Research program (CFDA 93.393) on July 1, 2026. The award funds a five-year prospective cohort study examining the relationship between perceived social obligations and clinical and patient-reported outcomes in 315 patients with advanced, poor-prognosis cancer. The research tests the hypothesis that higher patient-reported...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, School of Nursing, $723,569 under the Cancer Cause and Prevention Research program (CFDA 93.393) on September 1, 2026, to conduct a prospective epidemiologic study examining associations between the human gut microbiome and postmenopausal breast cancer risk. The research leverages the Nurses' Health Study II cohort, which includes over 18,000 women with pre-diagnostic stool samples and repeated assessments of...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $303,431 on August 13, 2026, under the Cancer Research Manpower program (CFDA 93.398) to implement breast cancer early detection measures in primary healthcare facilities in Botswana. The award funds a five-year implementation research project guided by the Integrative Systems Praxis for Implementation Research (INSPIRE) methodology. The project will conduct key informant...
- The National Cancer Institute awarded Hackensack University Medical Center $769,923 on July 20, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a community-based lung cancer screening intervention study. The funded project, CLEAR-LUNG, tests the effectiveness of Witness Project Lung—a culturally tailored, peer- and narrative-based intervention—versus a time- and attention-matched general cancer education program on verified lung cancer screening completion...
- The National Cancer Institute awarded Rutgers, The State University of New Jersey, School of Nursing $654,688 on April 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a comprehensive retrospective analysis of the implementation of local flavored cigar restriction policies across the United States. The research will assess real-world policy implementation strategies, capitalize on natural experiments in municipal policy adoption, and identify which...
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $516,808 under the Cancer Treatment Research program (CFDA 93.395) on June 1, 2026, to elucidate the mechanism of targeting methionine synthase (MTR) to enhance anti-tumor immunity in KRAS-driven lung cancer. The recipient will conduct research to understand how MTR targeting enhances immune responses in KRAS-driven non-small cell lung cancer (NSCLC), which exhibits...
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences (RBHS)-School of Nursing received a $403,689 Project Grant award from the National Cancer Institute (NCI) effective August 1, 2025, through July 31, 2027, under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant funds research investigating the influence of menthol cigarette smoking on lung cancer screening eligibility within a national prospective cohort study....
- The National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $651,545 on September 1, 2026, under the Cancer Treatment Research program (CFDA 93.395) to investigate the meningeal lymphatic system as a pathogenic driver of chemotherapy-induced cognitive impairment in cancer survivors. The research targets chemobrain, a persistent cognitive dysfunction affecting pediatric and adult cancer survivors whose underlying mechanisms remain...
- The National Institutes of Health National Cancer Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $678,215 on August 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to evaluate a social media-delivered sun safety intervention for parents and children in middle childhood. The Sun Safe Families intervention uses a Facebook-based platform to reach parents of 8- to 12-year-old children and improve sun protection...
- The National Cancer Institute awarded Rutgers The State University of New Jersey $672,960 on June 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to investigate the implications of EP300 deficiency in adult T-cell leukemia/lymphoma (ATLL). The research addresses mechanisms underlying chemo-refractory ATLL in North American patients, who exhibit overall survival of only 6.9 months. The project leverages a unique collection of EP300-mutant ATLL cells and an EP300-specific PROTAC...